SYK vs ZBH
SYK and ZBH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | SYKSTRYKER CORP | ZBHZIMMER BIOMET HOLDINGS, INC. |
|---|---|---|
| Market cap | $121.73B | $18.96B |
| P/E (TTM) | 32.9 | 24.1 |
| P/B | 10.38 | 1.50 |
| P/S | 4.9x | 2.3x |
| Dividend yield | 1.05% | 1.00% |
| Revenue | $25.84B(TTM) | $8.51B(TTM) |
| Revenue growth (YoY) | 11.2% | 7.2% |
| Net income | $3.73B(TTM) | $806.70M(TTM) |
| Earnings growth (YoY) | 8.5% | -22.0% |
| EPS, diluted | $9.65(TTM) | $4.12(TTM) |
| EBIT margin | 19.5% | 13.3% |
| ROE | 27.7% | 5.6% |
| ROIC | 15.1% | 5.0% |
| Piotroski F | 8/9 | 6/9 |
| 1y total return | -16.7% | -4.1% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: SYK frente a ZBH
| Métrica | SYK | ZBH |
|---|---|---|
| Valor final | $32.5K | $9.3K |
| Retorno total | +225.5% | -6.6% |
| CAGR | +12.1% | -0.7% |
| Volatilidad | 26.6% | 28.4% |
| Sharpe | 0.42 | -0.02 |
| Sortino | 0.59 | -0.03 |
| Caída máxima | -43.8% | -53.5% |
Basado en 2600 días de negociación comunes, 2016-04-29 → 2026-09-01 · tasa libre de riesgo 3.92% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)